Assembly Biosciences annual revenue
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Assembly Biosciences Revenue Growth & History (ASMB)
Assembly Biosciences reported $72.3M in revenue for fiscal 2025, an increase of 153.52% from the previous fiscal year.
View full Assembly Biosciences company overviewAssembly Biosciences annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $72.3M | $43.8M | +153.52% |
| 2024 | 2024-12-31 | $28.5M | $21.4M | +298.16% |
| 2023 | 2023-12-31 | $7.2M | $7.2M | — |
| 2022 | 2022-12-31 | $0 | −$6.3M | −100.00% |
| 2021 | 2021-12-31 | $6.3M | −$72.9M | −92.09% |
| 2020 | 2020-12-31 | $79.1M | $63.1M | +395.55% |
| 2019 | 2019-12-31 | $16.0M | $1.2M | +7.83% |
| 2018 | 2018-12-31 | $14.8M | $5.8M | +64.14% |
| 2017 | 2017-12-31 | $9.0M | $9.0M | — |
| 2016 | 2016-12-31 | $0 | — | — |
Assembly Biosciences quarterly revenue
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q3.21
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $13.4M | $3.7M | +38.94% |
| Q1 2026 | 2026-03-31 | $8.2M | −$1.2M | −12.80% |
| Q4 2025 | 2025-12-31 | $42.5M | $35.1M | +477.26% |
| Q3 2025 | 2025-09-30 | $10.8M | $3.9M | +57.62% |
| Q2 2025 | 2025-06-30 | $9.6M | $1.1M | +12.81% |
| Q1 2025 | 2025-03-31 | $9.4M | $3.6M | +62.82% |
| Q4 2024 | 2024-12-31 | $7.4M | $194,000 | +2.71% |
| Q3 2024 | 2024-09-30 | $6.8M | $6.8M | — |
| Q2 2024 | 2024-06-30 | $8.5M | $8.5M | — |
| Q1 2024 | 2024-03-31 | $5.8M | $5.8M | — |
| Q4 2023 | 2023-12-31 | $7.2M | — | — |
| Q3 2023 | 2023-09-30 | $0 | — | — |
| Q2 2023 | 2023-06-30 | $0 | — | — |
| Q1 2023 | 2023-03-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $6.3M | −$28.4M | −81.93% |
| Q4 2020 | 2020-12-31 | $1.0M | −$3.7M | −78.25% |
| Q3 2020 | 2020-09-30 | $34.6M | $30.4M | +718.03% |
| Q2 2020 | 2020-06-30 | $39.4M | $36.3M | +1178.44% |
| Q1 2020 | 2020-03-31 | $4.1M | $196,000 | +5.05% |
| Q4 2019 | 2019-12-31 | $4.8M | $1.0M | +27.63% |
| Q3 2019 | 2019-09-30 | $4.2M | −$55,000 | −1.28% |
| Q2 2019 | 2019-06-30 | $3.1M | −$138,000 | −4.29% |
| Q1 2019 | 2019-03-31 | $3.9M | $320,000 | +8.98% |
| Q4 2018 | 2018-12-31 | $3.7M | $420,000 | +12.67% |
| Q3 2018 | 2018-09-30 | $4.3M | $1.6M | +61.13% |
| Q2 2018 | 2018-06-30 | $3.2M | $859,000 | +36.41% |
| Q1 2018 | 2018-03-31 | $3.6M | $2.9M | +421.20% |
| Q4 2017 | 2017-12-31 | $3.3M | — | — |
| Q3 2017 | 2017-09-30 | $2.7M | — | — |
| Q2 2017 | 2017-06-30 | $2.4M | — | — |
| Q1 2017 | 2017-03-31 | $684,000 | — | — |
Assembly Biosciences revenue growth trends
Over the last five reported fiscal years, revenue declined from $79.1M to $72.3M, a compound annual decline of 1.78%. Assembly Biosciences's latest reported quarter, Q2 2026, generated $13.4M in revenue, an increase of 38.94% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Assembly Biosciences source filings ↗